Epithalon vs Melanotan II
A comprehensive, data-driven comparison of Epithalon (Epitalon) and Melanotan II (MT-2). Compare efficacy, side effects, costs, FDA approval status, and clinical evidence to make an informed decision.
Side-by-Side Comparison
| Property | Epithalon Epitalon, Epithalone | Melanotan II MT-2, Melanotan 2 |
|---|---|---|
| FDA Status | Not submitted | Not submitted |
| Category | Anti-Aging | Sexual Health |
| Primary Use | Anti-aging and longevity research | Tanning and sexual dysfunction (research) |
| Weight Loss % | N/A | N/A |
| Monthly Cost | $40 - $80/mo | $30 - $60/mo |
| Administration | Subcutaneous injection | Subcutaneous injection |
| Typical Dose | 5-10mg per cycle (10-20 days, 2-3x per year) | 0.25-1mg 2-3x per week |
| Frequency | Cyclical | As needed |
| Mechanism | Tetrapeptide that may activate telomerase enzyme to lengthen telomeres and potentially extend cellular lifespan | Melanocortin receptor agonist that stimulates melanogenesis for tanning and has effects on sexual arousal |
| Common Side Effects |
|
|
| Serious Side Effects |
|
|
| Evidence Quality | Emerging | Low |
| Clinical Trial Phase | N/A | N/A |
Key Differences
- 1Melanotan II is generally more affordable ($30 - $60/mo) compared to Epithalon ($40 - $80/mo).
- 2Epithalon is dosed cyclical, while Melanotan II is as needed.
- 3Melanotan II has low-quality evidence, while Epithalon has emerging-quality evidence.
- 4They belong to different categories: Epithalon (Anti-Aging) vs Melanotan II (Sexual Health).
Which Is Better For...
Melanotan II
More budget-friendly option with lower monthly costs
Melanotan II
More convenient dosing schedule (as needed)
Epithalon
Fewer commonly reported side effects
Melanotan II
Stronger clinical evidence base to support its use
Cost Comparison
| Peptide | Monthly Cost Range | FDA Status | Manufacturer |
|---|---|---|---|
| Epithalon | $40 - $80/mo | Not submitted | Various research labs |
| Melanotan II | $30 - $60/mo | Not submitted | Various research labs |
Prices are estimated monthly costs and may vary based on pharmacy, insurance coverage, and manufacturer assistance programs. Costs for non-FDA-approved peptides reflect research compound pricing.
Frequently Asked Questions
Epithalon works via Tetrapeptide that may activate telomerase enzyme to lengthen telomeres and potentially extend. Melanotan II works via Melanocortin receptor agonist that stimulates melanogenesis for tanning and has effects on. They differ in FDA approval status, efficacy data, and cost.
Epithalon typically costs $40 - $80/mo, while Melanotan II costs $30 - $60/mo. Prices may vary by pharmacy, insurance coverage, and manufacturer programs.
Epithalon is not FDA-approved (Not submitted). Melanotan II is not FDA-approved (Not submitted). FDA approval indicates the treatment has met rigorous safety and efficacy standards.
Common side effects of Epithalon include Injection site reactions, Mild drowsiness, Vivid dreams. Common side effects of Melanotan II include Nausea, Flushing, Spontaneous erections. Always consult a healthcare provider about potential side effects.
Switching between peptide therapies should only be done under the guidance of a qualified healthcare provider. They can evaluate your medical history, current response, and determine the safest transition protocol.
Learn More
Epithalon is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) researched primarily in Russia for its potential anti-aging properties. The proposed mechanism involves activation of telomerase, an enzyme that...
View Full Epithalon GuideMelanotan II is a synthetic analog of alpha-melanocyte stimulating hormone that binds to melanocortin receptors. Originally developed for skin tanning protection against UV damage, it was found to hav...
View Full Melanotan II GuideOther Popular Comparisons
Medical Disclaimer
The information provided on this page is for educational and informational purposes only and does not constitute medical advice. This comparison between Epithalon and Melanotan II should not be used as a substitute for professional medical guidance. Always consult a qualified healthcare provider before starting, stopping, or modifying any peptide therapy. Clinical data cited may be from ongoing trials and is subject to change. Individual results may vary significantly. PeptideVS does not endorse, recommend, or promote the use of any specific peptide for medical treatment.